At present, the new covid-19 coronavirus has spread to more than 180 countries around the world. Its economic impact on the world is more than that of the financial crisis in 2008. Many production and consumption will stop. However, analysts are optimistic about NVIDIA's GPU chip, believing that this virus epidemic will benefit NVIDIA.
Needham analyst Rajvindra Gill raised yesterdayNVIDIA company's target share price rose 17% to $249, rating has also been upgraded from holding to buying.
He believes that the popularity of covid-19 new coronavirus will promote the growth of NVIDIA graphics card demand,Because GPU based accelerators can speed up the analysis of human genome。
In addition, rajvindra gill also believes that the epidemic will accelerate the development of Ai Ai Ai technology in the world, and NVIDIA's GPU is expected to be a key factor in promoting this transformation.
In rajvindra Gill's view, GPU for medical applications will gradually become popular with the popularity of covid-19.
Although this may not sound comfortable, GPU accelerated supercomputing does play a role in fighting covid-19 virus.
NVIDIA recently mentioned,Professor Wei Dongqing's team of Shanghai Jiaotong University used 5 sets of dgx-2 AI supercomputing supercomputing developed by NVIDIA to search for antiviral drugs, the screening efficiency has increased from the previous two months to two days, and the number of papers is more than ten times of the previous.
NVIDIA said that with the help of ultra-high performance computing resources, and in combination with advanced medical research deep learning software, The team's drug research process has been greatly accelerated, and the simulation, which would take one to two months to complete, is now completed in only one to two days。
Not only has the work efficiency been greatly improved, NVIDIA also emphasizes that the speed of publishing scientific research results has changed. In the past, Professor Wei published 4-5 papers every three years, no more than 10 at most.